Photocure ASA PHCUF:OTCPK

*Data is delayed | Exchange | USD
Last | 03/06/24 EDT
5.95UNCH (UNCH)
52 week range
4.21 - 6.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.95
  • 52 Week High6.50
  • 52 Week High Date01/23/24
  • 52 Week Low4.21
  • 52 Week Low Date05/18/23

Key Stats

  • Market Cap136.17M
  • Shares Out27.11M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-2.46

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.95
  • 52 Week High6.50
  • 52 Week High Date01/23/24
  • 52 Week Low4.21
  • 52 Week Low Date05/18/23
  • Market Cap136.17M
  • Shares Out27.11M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-2.46

RATIOS/PROFITABILITY

  • EPS (TTM)0.00
  • P/E (TTM)6,028.37
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Photocure ASA

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s...
Dylan Hallerberg
Interim Chairman of the Board
Daniel Schneider
President, Chief Executive Officer
Erik Dahl
Chief Financial Officer
Grete Hogstad
Vice President Global Strategic Marketing and BD
Patricia Kelly
Vice President Global Human Resources
Address
Hoffsveien 4
Oslo
0275
Norway